544759 — Goldline Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹467.42m
- IN₹554.51m
- IN₹280.56m
Annual cashflow statement for Goldline Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 4.01 | 25.2 | 38.6 |
| Depreciation | |||
| Non-Cash Items | 18.2 | 16.5 | 18.1 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.072 | -14.2 | -36 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 23.9 | 29.2 | 23.2 |
| Capital Expenditures | -11.1 | -11.1 | -2.07 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 0.733 | 0 | 3.69 |
| Sale of Fixed Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -10.3 | -11.1 | 1.62 |
| Financing Cash Flow Items | -18.3 | -16.8 | -19.4 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -14.4 | -10.8 | -20.3 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.868 | 7.36 | 4.5 |